Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

समान संसाधन

• Plasma Elevations of Tumor Necrosis Factor-Receptor-1 at Day 7 Post Allogeneic Transplant Correlate with Graft Versus Host Disease Severity and Overall Survival in Pediatric Patients
  द्वारा: Kitko, Carrie L., और अन्य
  प्रकाशित: (2008)
• Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
  द्वारा: Levine, John E., और अन्य
  प्रकाशित: (2008)
• Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation
  द्वारा: Yanik, Gregory A., और अन्य
  प्रकाशित: (2011)
• Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT
  द्वारा: Choi, Sung Won, और अन्य
  प्रकाशित: (2017)
• The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
  द्वारा: Yanik, Gregory A., और अन्य
  प्रकाशित: (2008)